Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids (Q26996521)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids	scientific article

Statements

scholarly article

2 references

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25646366%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

Europe PubMed Central

Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25646366%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

neuroendocrinology

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

neuroendocrine tumor

1 reference

based on heuristic

inferred from title

carcinoid tumor

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25646366%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25646366%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25646366%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

M E Caplin

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25646366%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

E Baudin

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25646366%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

P Filosso

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25646366%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

M Garcia-Yuste

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25646366%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

K Oberg

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25646366%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

G Pelosi

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25646366%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

R E Rossi

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25646366%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

W D Travis

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25646366%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

ENETS consensus conference participants

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25646366%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

language of work or name

1 reference

publication date

2 February 2015

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25646366%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Annals of Oncology

2 references

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25646366%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

26

2 references

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25646366%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

8

2 references

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25646366%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1604-1620

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25646366%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Neuroendocrine carcinomas of the lung: a critical analysis

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Neuroendocrine neoplasia. Current concepts.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Revised classification of neuroendocrine tumors of the lung, pancreas and gut.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Pulmonary carcinoid: presentation, diagnosis, and outcome in 142 cases in Israel and review of 640 cases from the literature

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Bronchopulmonary carcinoids in Iceland 1955-1984. A retrospective clinical and histopathologic study

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Neuroendocrine tumor epidemiology: contrasting Norway and North America.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Epidemiology of carcinoid neoplasms in Vaud, Switzerland, 1974-97.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

A 5-decade analysis of 13,715 carcinoid tumors

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Carcinoid lung tumors--incidence, treatment and outcomes: a population-based study

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

7201 carcinoids: increasing incidence overall and disproportionate mortality in the elderly.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Epidemiology and survival in patients with carcinoid disease in The Netherlands. An epidemiological study with 2391 patients

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Pulmonary neuroendocrine tumors: incidence and prognosis of histological subtypes. A population-based study in Denmark

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Survival from rare cancer in adults: a population-based study

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Comparison of pathologic findings of baseline and annual repeat cancers diagnosed on CT screening.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Pathologic and molecular features of screening low-dose computed tomography (LDCT)-detected lung cancer: a baseline and 2-year repeat study.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Bronchopulmonary neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Prognostic factors for gastrointestinal and bronchopulmonary carcinoid tumors

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Risk factors associated with neuroendocrine tumors: A U.S.-based case-control study

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Bronchial carcinoid tumors: surgical management and long-term outcome.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Metastatic carcinoid tumors: a clinical review

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Primary epithelial lung malignancies in the pediatric population

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Bronchial carcinoid tumours in children: surgical treatment and outcome in a single institution.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Primary lung tumors in children and adolescents: a 90-year experience

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Initial bronchoscopic treatment for patients with intraluminal bronchial carcinoids.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Bronchial carcinoids. A review of 22 cases

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Carcinoid tumors of the lung: immuno- and ligandohistochemistry, analysis of integrated optical density, syntactic structure analysis, clinical data, and prognosis of patients treated surgically

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Genetics of neuroendocrine and carcinoid tumours

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Bronchopulmonary carcinoid in multiple endocrine neoplasia type 1.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

The IASLC Lung Cancer Staging Project: proposals for the inclusion of broncho-pulmonary carcinoid tumors in the forthcoming (seventh) edition of the TNM Classification for Lung Cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Grading the neuroendocrine tumors of the lung: an evidence-based proposal.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Revised classification of neuroendocrine tumours of the lung, pancreas and gut.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Multidirectional differentiation of Achaete-Scute homologue-1-defined progenitors in lung development and injury repair

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Functional facets of the pulmonary neuroendocrine system

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

The molecular basis of lung morphogenesis

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Comparative epidemiology of carcinoid and oat-cell tumors of the lung

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Typical and atypical pulmonary carcinoid tumor overdiagnosed as small-cell carcinoma on biopsy specimens: a major pitfall in the management of lung cancer patients

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Limited role of Ki-67 proliferative index in predicting overall short-term survival in patients with typical and atypical pulmonary carcinoid tumors

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Partitioning of bronchopulmonary carcinoids in two different prognostic categories by ki-67 score

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Objective quantification of the Ki67 proliferative index in neuroendocrine tumors of the gastroenteropancreatic system: a comparison of digital image analysis with manual methods

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Interobserver agreement of proliferation index (Ki-67) outperforms mitotic count in pulmonary carcinoids

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the thorax (includes lung and thymus).

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Morphology and antigen expression profile of pulmonary neuroendocrine cells in reactive proliferations and diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH).

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: a systematic overview

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

What is DIPNECH?

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Spectrum of pulmonary neuroendocrine cell proliferation: diffuse idiopathic pulmonary neuroendocrine cell hyperplasia, tumorlet, and carcinoids

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Hormonally defined pancreatic and duodenal neuroendocrine tumors differ in their transcription factor signatures: expression of ISL1, PDX1, NGN3, and CDX2.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Clinical significance of neuroendocrine carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Somatostatin receptor tissue distribution in lung neuroendocrine tumours: a clinicopathologic and immunohistochemical study of 218 'clinically aggressive' cases.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

The biological characterization of neuroendocrine tumors: the role of neuroendocrine markers

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Neuron-specific enolase and chromogranin A as markers of neuroendocrine tumours

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Proceedings of the IASLC International Workshop on Advances in Pulmonary Neuroendocrine Tumors 2007.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Surgical treatment of neuroendocrine tumors of the lung.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Paraneoplastic syndromes secondary to neuroendocrine tumours.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1).

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Guidelines for diagnosis and therapy of MEN type 1 and type 2.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Bronchial carcinoid tumors of the thorax: spectrum of radiologic findings

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

CT features of peripheral pulmonary carcinoid tumors.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Clinical-radiological presentation and outcome of surgically treated pulmonary carcinoid tumours: a long-term single institution experience

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Carcinoid tumours: predicting the location of the primary neoplasm based on the sites of metastases

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: radiological examinations

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Prediction and diagnosis of bone metastases in well-differentiated gastro-entero-pancreatic endocrine cancer: a prospective comparison of whole body magnetic resonance imaging and somatostatin receptor scintigraphy.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

(68)Ga-DOTA-NOC PET/CT in comparison with CT for the detection of bone metastasis in patients with neuroendocrine tumours.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Octreoscan in patients with bronchial carcinoid tumours

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Performance of (18)fluorodeoxyglucose-positron emission tomography and somatostatin receptor scintigraphy for high Ki67 (≥10%) well-differentiated endocrine carcinoma staging.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Tumors in the tracheobronchial tree: CT and FDG PET features

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

The utility of fluorodeoxyglucose positron emission tomography in the evaluation of carcinoid tumors presenting as pulmonary nodules

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

68Ga-DOTA-NOC: a new PET tracer for evaluating patients with bronchial carcinoid

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

A comparison of 68Ga-DOTATATE and 18F-FDG PET/CT in pulmonary neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

The role of 68Ga-DOTATATE PET in patients with neuroendocrine tumors and negative or equivocal findings on 111In-DTPA-octreotide scintigraphy

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Clinical PET of neuroendocrine tumors using 64Cu-DOTATATE: first-in-humans study

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Whole-body (11)C-5-hydroxytryptophan positron emission tomography as a universal imaging technique for neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and computed tomography

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Diagnosis of lung cancer: the guidelines.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Diagnosis of peripheral pulmonary carcinoid tumor using endobronchial ultrasound

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Pulmonary assessment for general thoracic surgery

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: echocardiography

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Management of carcinoid tumors

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Long-term survival after surgical management of neuroendocrine hepatic metastases

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Carcinoid tumors of the lung.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Diagnosis and treatment of bronchial carcinoid tumors: clinical and pathological review of 120 operated patients

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Carcinoid tumours of the bronchus: a 33 year experience

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Limited and radical resection for tracheal and bronchopulmonary carcinoid tumour. Report on 227 cases

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Metachronous bronchial carcinoid tumor

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Bronchoscopic cryotherapy treatment of isolated endoluminal typical carcinoid tumor.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Nd:YAG laser bronchoscopy. A five-year experience with 1,396 applications in 1,000 patients

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Pulmonary neuroendocrine/carcinoid tumors: a review article

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: biotherapy

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Long-term survival of atypical bronchial carcinoids with liver metastases, treated with octreotide

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Antitumour activity of somatostatin analogues in progressive metastatic neuroendocrine tumours

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Prospective, randomized, multicenter trial on the antiproliferative effect of lanreotide, interferon alfa, and their combination for therapy of metastatic neuroendocrine gastroenteropancreatic tumors--the International Lanreotide and Interferon Alfa

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Consensus guidelines for the management of patients with liver metastases from digestive (neuro)endocrine tumors: foregut, midgut, hindgut, and unknown primary

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

ENETS consensus guidelines for the management of bone and lung metastases from neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

The clinical value of [90Y-DOTA]-D-Phe1-Tyr3-octreotide (90Y-DOTATOC) in the treatment of neuroendocrine tumours: a clinical phase II study

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Response, survival, and long-term toxicity after therapy with the radiolabeled somatostatin analogue [90Y-DOTA]-TOC in metastasized neuroendocrine cancers

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Treatment with the radiolabeled somatostatin analog [177 Lu-DOTA 0,Tyr3]octreotate: toxicity, efficacy, and survival

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Phase II/III study of doxorubicin with fluorouracil compared with streptozocin with fluorouracil or dacarbazine in the treatment of advanced carcinoid tumors: Eastern Cooperative Oncology Group Study E1281.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Continuous 5-fluorouracil infusion plus long acting octreotide in advanced well-differentiated neuroendocrine carcinomas. A phase II trial of the Piemonte oncology network

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

ENETS consensus guidelines for the management of brain, cardiac and ovarian metastases from neuroendocrine tumors.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Experience in treatment of metastatic pulmonary carcinoid tumors

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Capecitabine and streptozocin ± cisplatin in advanced gastroenteropancreatic neuroendocrine tumours.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

The Akt-mTOR tango and its relevance to cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Everolimus for advanced pancreatic neuroendocrine tumors.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Sunitinib malate for the treatment of pancreatic neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Activity of sunitinib in patients with advanced neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Targeting vascular endothelial growth factor in advanced carcinoid tumor: a random assignment phase II study of depot octreotide with bevacizumab and pegylated interferon alpha-2b

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Prospective study of bevacizumab plus temozolomide in patients with advanced neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Hitting the target: where do molecularly targeted therapies fit in the treatment scheduling of neuroendocrine tumours?

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Tumorlets in Familial History of Bronchopulmonary Carcinoid

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

The impact of stage and cell type on the prognosis of pulmonary neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Pulmonary atypical carcinoid: Predictors of survival in 106 cases

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Neuroendocrine tumors: A population-based study of incidence and survival in Girona province, 1994–2004

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Are capecitabine and oxaliplatin (XELOX) suitable treatments for progressing low-grade and high-grade neuroendocrine tumours?

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV041

21 January 2018

Identifiers

10.1093/ANNONC/MDV041

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25646366%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25646366%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q26996521&oldid=1594576325"